vs
Alkermes plc.（ALKS）与南玻集团（CSGS）财务数据对比。点击上方公司名可切换其他公司
Alkermes plc.的季度营收约是南玻集团的1.2倍（$384.5M vs $323.1M），Alkermes plc.净利率更高（12.8% vs 2.2%，领先10.7%），南玻集团同比增速更快（2.0% vs -10.6%），Alkermes plc.自由现金流更多（$170.0M vs $55.8M），过去两年Alkermes plc.的营收复合增速更高（4.8% vs 4.6%）
Alkermes plc是一家全产业链布局的生物制药企业，专注于精神障碍与神经系统疾病相关药物的研发。公司1987年由迈克尔·沃尔创立，2011年9月与原Élan集团旗下的药物制剂及生产部门Elan Drug Technologies合并，总部位于都柏林，在马萨诸塞州沃尔瑟姆设有研发中心，俄亥俄州威尔明顿建有生产基地。
中国南玻集团股份有限公司是中国规模最大的建筑玻璃生产商，业务涵盖浮法玻璃、建筑玻璃、显示玻璃、汽车玻璃、镀膜玻璃、镜子、彩滤玻璃、太阳能玻璃及节能玻璃等各类玻璃产品的研发、生产与销售，产品广泛应用于建筑、消费电子、新能源汽车、光伏等多个领域。
ALKS vs CSGS — 直观对比
营收规模更大
ALKS
是对方的1.2倍
$323.1M
营收增速更快
CSGS
高出12.6%
-10.6%
净利率更高
ALKS
高出10.7%
2.2%
自由现金流更多
ALKS
多$114.2M
$55.8M
两年增速更快
ALKS
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $384.5M | $323.1M |
| 净利润 | $49.3M | $7.0M |
| 毛利率 | 88.0% | 50.0% |
| 营业利润率 | 15.1% | 9.0% |
| 净利率 | 12.8% | 2.2% |
| 营收同比 | -10.6% | 2.0% |
| 净利润同比 | -66.3% | -79.7% |
| 每股收益（稀释后） | $0.29 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALKSCSGS
| Q4 25 | $384.5M | $323.1M | ||
| Q3 25 | $394.2M | $303.6M | ||
| Q2 25 | $390.7M | $297.1M | ||
| Q1 25 | $306.5M | $299.5M | ||
| Q4 24 | $430.0M | $316.7M | ||
| Q3 24 | $378.1M | $295.1M | ||
| Q2 24 | $399.1M | $290.3M | ||
| Q1 24 | $350.4M | $295.1M |
净利润ALKSCSGS
| Q4 25 | $49.3M | $7.0M | ||
| Q3 25 | $82.8M | $20.5M | ||
| Q2 25 | $87.1M | $12.3M | ||
| Q1 25 | $22.5M | $16.1M | ||
| Q4 24 | $146.5M | $34.5M | ||
| Q3 24 | $92.4M | $19.1M | ||
| Q2 24 | $91.4M | $13.8M | ||
| Q1 24 | $36.8M | $19.5M |
毛利率ALKSCSGS
| Q4 25 | 88.0% | 50.0% | ||
| Q3 25 | 86.9% | 48.1% | ||
| Q2 25 | 87.3% | 49.5% | ||
| Q1 25 | 83.9% | 48.4% | ||
| Q4 24 | 85.6% | 51.3% | ||
| Q3 24 | 83.3% | 49.4% | ||
| Q2 24 | 84.6% | 47.3% | ||
| Q1 24 | 83.3% | 46.5% |
营业利润率ALKSCSGS
| Q4 25 | 15.1% | 9.0% | ||
| Q3 25 | 22.6% | 10.0% | ||
| Q2 25 | 23.8% | 10.0% | ||
| Q1 25 | 4.5% | 9.8% | ||
| Q4 24 | 37.8% | 13.4% | ||
| Q3 24 | 27.7% | 10.8% | ||
| Q2 24 | 27.5% | 8.8% | ||
| Q1 24 | 12.4% | 10.8% |
净利率ALKSCSGS
| Q4 25 | 12.8% | 2.2% | ||
| Q3 25 | 21.0% | 6.7% | ||
| Q2 25 | 22.3% | 4.1% | ||
| Q1 25 | 7.3% | 5.4% | ||
| Q4 24 | 34.1% | 10.9% | ||
| Q3 24 | 24.4% | 6.5% | ||
| Q2 24 | 22.9% | 4.8% | ||
| Q1 24 | 10.5% | 6.6% |
每股收益（稀释后）ALKSCSGS
| Q4 25 | $0.29 | $0.24 | ||
| Q3 25 | $0.49 | $0.73 | ||
| Q2 25 | $0.52 | $0.44 | ||
| Q1 25 | $0.13 | $0.57 | ||
| Q4 24 | $0.88 | $1.20 | ||
| Q3 24 | $0.55 | $0.67 | ||
| Q2 24 | $0.53 | $0.48 | ||
| Q1 24 | $0.21 | $0.68 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $388.6M | $180.0M |
| 总债务越低越好 | — | $539.5M |
| 股东权益账面价值 | $1.8B | $283.7M |
| 总资产 | $2.5B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 1.90× |
8季度趋势，按日历期对齐
现金及短期投资ALKSCSGS
| Q4 25 | $388.6M | $180.0M | ||
| Q3 25 | $616.4M | $158.4M | ||
| Q2 25 | $521.2M | $145.9M | ||
| Q1 25 | $399.8M | $136.0M | ||
| Q4 24 | $291.1M | $161.8M | ||
| Q3 24 | $396.3M | $118.4M | ||
| Q2 24 | $535.1M | $110.4M | ||
| Q1 24 | $420.8M | $120.8M |
总债务ALKSCSGS
| Q4 25 | — | $539.5M | ||
| Q3 25 | — | $538.6M | ||
| Q2 25 | — | $537.8M | ||
| Q1 25 | — | $537.6M | ||
| Q4 24 | — | $538.5M | ||
| Q3 24 | — | $539.5M | ||
| Q2 24 | — | $540.5M | ||
| Q1 24 | — | $541.5M |
股东权益ALKSCSGS
| Q4 25 | $1.8B | $283.7M | ||
| Q3 25 | $1.7B | $289.5M | ||
| Q2 25 | $1.6B | $290.7M | ||
| Q1 25 | $1.5B | $283.1M | ||
| Q4 24 | $1.5B | $282.6M | ||
| Q3 24 | $1.3B | $288.4M | ||
| Q2 24 | $1.3B | $273.3M | ||
| Q1 24 | $1.3B | $269.3M |
总资产ALKSCSGS
| Q4 25 | $2.5B | $1.5B | ||
| Q3 25 | $2.3B | $1.5B | ||
| Q2 25 | $2.3B | $1.4B | ||
| Q1 25 | $2.1B | $1.4B | ||
| Q4 24 | $2.1B | $1.5B | ||
| Q3 24 | $2.2B | $1.4B | ||
| Q2 24 | $2.2B | $1.4B | ||
| Q1 24 | $2.1B | $1.3B |
负债/权益比ALKSCSGS
| Q4 25 | — | 1.90× | ||
| Q3 25 | — | 1.86× | ||
| Q2 25 | — | 1.85× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | — | 1.91× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | 1.98× | ||
| Q1 24 | — | 2.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $170.1M | $59.2M |
| 自由现金流经营现金流 - 资本支出 | $170.0M | $55.8M |
| 自由现金流率自由现金流/营收 | 44.2% | 17.3% |
| 资本支出强度资本支出/营收 | 0.0% | 1.1% |
| 现金转化率经营现金流/净利润 | 3.45× | 8.46× |
| 过去12个月自由现金流最近4个季度 | $480.3M | $141.4M |
8季度趋势，按日历期对齐
经营现金流ALKSCSGS
| Q4 25 | $170.1M | $59.2M | ||
| Q3 25 | $101.7M | $47.9M | ||
| Q2 25 | $150.2M | $37.3M | ||
| Q1 25 | $98.8M | $11.5M | ||
| Q4 24 | $190.4M | $82.5M | ||
| Q3 24 | $81.6M | $39.5M | ||
| Q2 24 | $146.0M | $43.1M | ||
| Q1 24 | $21.1M | $-29.4M |
自由现金流ALKSCSGS
| Q4 25 | $170.0M | $55.8M | ||
| Q3 25 | $84.4M | $43.9M | ||
| Q2 25 | $137.2M | $34.6M | ||
| Q1 25 | $88.7M | $7.1M | ||
| Q4 24 | $180.6M | $76.6M | ||
| Q3 24 | $73.3M | $32.0M | ||
| Q2 24 | $138.9M | $38.8M | ||
| Q1 24 | $12.8M | $-34.1M |
自由现金流率ALKSCSGS
| Q4 25 | 44.2% | 17.3% | ||
| Q3 25 | 21.4% | 14.5% | ||
| Q2 25 | 35.1% | 11.6% | ||
| Q1 25 | 28.9% | 2.4% | ||
| Q4 24 | 42.0% | 24.2% | ||
| Q3 24 | 19.4% | 10.8% | ||
| Q2 24 | 34.8% | 13.4% | ||
| Q1 24 | 3.6% | -11.6% |
资本支出强度ALKSCSGS
| Q4 25 | 0.0% | 1.1% | ||
| Q3 25 | 4.4% | 1.3% | ||
| Q2 25 | 3.3% | 0.9% | ||
| Q1 25 | 3.3% | 1.5% | ||
| Q4 24 | 2.3% | 1.9% | ||
| Q3 24 | 2.2% | 2.5% | ||
| Q2 24 | 1.8% | 1.5% | ||
| Q1 24 | 2.4% | 1.6% |
现金转化率ALKSCSGS
| Q4 25 | 3.45× | 8.46× | ||
| Q3 25 | 1.23× | 2.34× | ||
| Q2 25 | 1.72× | 3.04× | ||
| Q1 25 | 4.40× | 0.71× | ||
| Q4 24 | 1.30× | 2.39× | ||
| Q3 24 | 0.88× | 2.07× | ||
| Q2 24 | 1.60× | 3.12× | ||
| Q1 24 | 0.57× | -1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALKS
| Vivitrol | $124.1M | 32% |
| Aristada And Aristada Initio | $97.2M | 25% |
| LYBALVI | $94.1M | 24% |
| Royalty | $65.7M | 17% |
| Manufacturing Revenue | $3.3M | 1% |
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
